Navigation Links
Webcast Advisory - NUCRYST Pharmaceuticals Webcast of Conference Call to Discuss 2007 Third Quarter Results
Date:10/30/2007

Wednesday, November 7, 2007 4:30 p.m. EST http://www.nucryst.com

WAKEFIELD, MA, Oct. 30 /PRNewswire-FirstCall/ - NUCRYST Pharmaceuticals Corp. will hold a webcast at 4:30 p.m. EST on Wednesday, November 7, 2007 regarding the company's 2007 third quarter results.

In addition to standard disclosure over wire services, a news release and financial statements will be posted on the NUCRYST web site. To listen to the call live on the Internet, please go to http://www.nucryst.com.

Thomas E. Gardner, Chairman, President & CEO and Eliot M. Lurier, Vice President, Finance & Administration and Chief Financial Officer will participate on the call.

An audio file of the call will be archived and posted on the NUCRYST web site.

NUCRYST Pharmaceuticals (NASDAQ: NCST; TSX: NCS) develops, manufactures and commercializes medical products that fight infection and inflammation using its patented atomically disordered nanocrystalline silver technology. Smith & Nephew plc sell a range of advanced wound care products under their Acticoat(TM) trade mark: Acticoat(TM) products incorporate NUCRYST's SILCRYST(TM) coatings and are sold in over 30 countries. NUCRYST is also developing pharmaceutical products to address medical conditions that are characterized by both infection and inflammation. The Company has developed its proprietary nanocrystalline silver in a powder form for use as an active pharmaceutical ingredient, referred to as NPI 32101.

SILCRYST(TM) is a trademark of NUCRYST Pharmaceuticals Corp.

Acticoat(TM) is a trademark of Smith & Nephew plc


'/>"/>
SOURCE NUCRYST Pharmaceuticals Corp.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1

Related medicine news :

1. WHO lifts HongKong advisory
2. FDA Issues Public Health Advisory on Tysabri, a New Drug for MS
3. Doctors Said – ‘Stop Pressurising NHS Advisory Bod’
4. Mercks Pain Reliever Arcoxia Rejected by US Federal Advisory Panel
5. FDA Advisory Against Anti-depressants to Be Expanded to Cover Young Adults too
6. FDA Advisory Against Anti-depressants to Be Expanded to Cover Young Adults too
7. LifeCycle Pharma Forms Scientific Advisory Board in Solid Organ Transplantation
8. Supply of Radiopharmaceuticals Hampered by Attacks
9. FDA approves Watson Pharmaceuticals Oxytrol patch
10. Ranbaxy Pharmaceuticals Inc awarded the prestigious outstanding supplier award received from Wal-Mart
11. Antigenics Pharmaceuticals plans for Phase III trial of its Melanoma vaccine
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/29/2017)... ... March 30, 2017 , ... Sublime Naturals and its ... Life" or "Wonder Spice", it has been used for thousands of years. , "The ... says Heshelow, author of " Turmeric: How to Use it For Your Wellness. Overcome ...
(Date:3/29/2017)... Baton Rouge, Louisiana (PRWEB) , ... March 29, ... ... trademarked HeartBoost in three Hours at a Walgreens store in Mississippi. AngioGenesis Labs, ... campaign at Walgreens Stores in two southeastern states. Ingredients in HeartBoost, an over ...
(Date:3/29/2017)... ... March 29, 2017 , ... Patients ... in Carnegie, OK, from Dr. Jamie Cameron, with or without a referral. The ... traditional orthodontic treatment. Depending on each patient’s case, treatment with the FASTBRACES system ...
(Date:3/29/2017)... ARNOLD, Md., and MINNETONKA, Minn. (PRWEB) , ... ... ... for the development of medical office buildings (MOBs) and other outpatient facilities, and ... research project to look exclusively at those questions, Revista and Healthcare Real Estate ...
(Date:3/29/2017)... ... 29, 2017 , ... An inventor from Raynham, Mass., knows ... in conjunction with my braces always rubbed against the inside of my cheeks, ... this problem." The O.B.S. was the result of his brainstorming. , This patent-pending ...
Breaking Medicine News(10 mins):
(Date:3/29/2017)... Research and Markets has announced the addition of the ... Centers & Forecast" report to their offering. ... The South Korean Proton Therapy Market is expected ... The Untapped Proton Therapy Market for South Korea ... Proton Therapy plays an important role in delivering comprehensive cancer care ...
(Date:3/29/2017)... -- The leader in accelerated orthodontics, OrthoAccel ® Technologies, ... Manal Ibrahim , Kenji Ojima , ... featured microlecture presenters at the AcceleDent ® booth ... Annual Session, April 21-25, 2017. Orthodontists and their staff ... 11:20 a.m. On the opening morning of AAO exhibitions, ...
(Date:3/29/2017)... March 29, 2017  Maxor National Pharmacy Services, LLC ... it has named Leah Bailey as General ... of the company. With more than 13 ... 8 years focused on health care, Bailey joins the ... at Prime, Bailey advised the PBM, Specialty, and Mail ...
Breaking Medicine Technology: